| MGMT-Unmethylated Glioblastoma studied in …STUDIED_INderived19 of 19show fewer |
|---|
| → studied in | NCT07452458Phase 3 · recruiting Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05236036Phase 1 · active not recruiting Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778602early Phase 1 · not yet recruiting Safety and Feasibility of First-line Avutometinib and Defactinib in Patients With Newly Diagnosed High-grade Gliomas · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06186401Phase 1 · recruiting Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07739017Phase 1 · not yet recruiting OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma · condition mapped CURATED_BROADER · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06991101Phase 2 · recruiting Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879250Phase 2 · recruiting WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04396860Phase 2/Phase 3 · completed Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06504381Phase 1/Phase 2 · recruiting DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03107780Phase 1 · terminated Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05734560Phase 1/Phase 2 · recruiting D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients · condition mapped CURATED_BROADER · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05909618Phase 2 · recruiting Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03452930Phase 1 · completed Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03250299Phase 1 · terminated Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05694416Phase 2 · unknown Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03367715Phase 2 · completed Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05033587Phase 2 · unknown Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma. · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04725214Phase 2 · unknown Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04224441Phase 2 · unknown Repurposing Chlorpromazine in the Treatment of Glioblastoma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (10 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |